Business Wire

Ant Group Unveils Cloud-based Cryptographic Computing Platform

5.7.2024 13:26:00 EEST | Business Wire | Press release

Share

Ant Group today unveiled SecretFlow Cloud, its cloud-based cryptographic computing platform, and a suite of cryptographic computing solutions tailored for large language models (LLMs) at the World Artificial Intelligence Conference in Shanghai.

Leveraging integrated software-hardware cryptographic computing technologies, these solutions enable the secure circulation of encrypted data throughout the hosting and inference processes of LLMs, safeguarding the integrity of LLM assets and data security while significantly enhancing data privacy protection. Providers can now encrypt and deploy their LLMs onto cloud environments effortlessly with a single click through its encrypted hosting service, safeguarding their valuable assets from compromise and theft. Meanwhile, the encrypted inference service ensures efficient data security and the protection of trade secrets during interactions with LLMs.

These solutions allow GPUs to perform computing tasks within trusted execution environments, notably reducing the cost and performance disparity between encrypted LLM inference and plaintext operations, providing a more cost-effective approach. The platform also integrates additional technologies such as memory and disk encryption, ensuring end-to-end encryption and secure cross-domain model hosting management. Additionally, a user-friendly remote attestation system allows for smooth verification through web interfaces, minimizing friction for users.

SecretFlow Cloud currently supports both public and private cloud deployments, and is compatible with commonly-used LLMs in the global market. For instance, in a public cloud setup, users can seamlessly build a new professional LLM on SecretFlow Cloud or migrate an existing LLM to the platform, with its secure LLM inference services ready in as few as 10 minutes with just a click. Moreover, users can purchase cryptographic computing resources on demand to meet their needs.

"Data is the most critical element in the application of LLMs, and cryptographic computing technology significantly enhances the utility of data in cross-domain scenarios," noted Dr. Lenx Wei, Vice President and Chief Technology Security Officer at Ant Group. "As LLMs evolve toward specialized professional domains and become essential productivity tools, cryptographic computing will play a vital role, particularly in fully unlocking the value of high-quality, domain-specific data sets."

According to Dr. Wei, while companies often deploy LLMs in private environments to address data security challenges, such methods can incur higher operational costs and compromise both service efficiency and quality, ultimately constraining the potential of LLMs. The cryptographic computing solutions offered by SecretFlow Cloud can effectively resolve these issues.

Looking forward, SecretFlow Cloud aims to further develop its cryptographic computing solutions to ensure data security throughout the full lifecycle of professional LLMs, including their creation, deployment, and service delivery.

Ant Group has been exploring privacy-preserving computing technologies since 2016 and released SecretFlow in 2022 as an open-source privacy-preserving computing framework that features an array of advanced technologies, including multiparty computation, federated learning, Trusted Execution Environments, Homomorphic Encryption, and Differential Privacy. Positioned at the forefront of cryptographic computing, SecretFlow Cloud represents a new generation of privacy-preserving computing technology, poised to overcome pain points in security, cost, and accessibility in data circulation. It offers a solution for instantly harnessing data value, akin to turning on a tap. To date, its technologies have been adopted in industries such as insurance, rural finance, healthcare, public services, and marketing.

About Ant Group

Ant Group aims to build the infrastructure and platforms to support the digital transformation of the service industry. Through continuous innovation, we strive to provide all consumers and small and micro businesses equal access to digital financial and other daily life services that are convenient, sustainable and inclusive.

For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240705154761/en/

Contacts

Media Inquiries
Vick Li Wei
Ant Group
Vick.lw@antgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 13:07:00 EEST | Press release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 02:17:00 EEST | Press release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

Grindr Nominates Three New Directors to Its Board of Directors1.5.2026 00:16:00 EEST | Press release

Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and marketplaces. He has held CEO and COO roles at scaled platforms including GoFundMe, Groupon, and Kayak-predecessor SideStep, and is currently CEO of leading electric aviation company H55. Lisa Gersh is a CEO and long-tenured public company director with deep experience across consumer brands, media, and commerce. She has served on the Hasbro (NASDAQ: HAS) board since 2010 and has led businesses including Oxygen Media, GOOP, and Alexander Wang. Fadi Hanna is Chief Risk Officer at Bloomberg L.P., overseeing enterprise risk across the organization. He previously worked at J.P. Morgan and has served on the board of Immigration Equality. “Over the last few years, we bu

The Empire State Building Celebrates 95 Years as the ‘World’s Most Famous Building’30.4.2026 23:42:00 EEST | Press release

The Empire State Building (ESB), the “World’s Most Famous Building,” will celebrate its 95th anniversary on May 1, 2026, with new offers at the Empire State Building Observation Deck, a special birthday tower lighting display, and a slate of celebrations to honor its legacy and future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430693323/en/ The Empire State Building Celebrates 95 Years as the ‘World’s Most Famous Building’ “The Empire State Building celebrates its 95th anniversary, still the ‘World’s Most Famous Building,’ a modernized, sustainability leader as technologically advanced today as the day she was completed, and the winner of #1 Top Attraction in the United States in Tripadvisor’s Travelers’ Choice Awards for 2026,” said Anthony E. Malkin, chairman and CEO of Empire State Realty Trust. Anniversary Offerings and Experiences To mark its 95th anniversary, the Empire State Building will debut new experiences

MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis30.4.2026 23:17:00 EEST | Press release

MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the power of the microbiome to restore immune balance, today announced that MH002, the Company’s lead rationally designed Live Biotherapeutic Product (LBP) candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate ulcerative colitis (UC). MH002 today is the most advanced LBP targeting inflammatory bowel disease (IBD)-specific mechanisms and is composed of a rationally designed microbial consortium of six well-characterized commensal strains. The FDA’s Fast Track is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. The purpose is to get important drugs to patients earlier. Fast Track designation enables frequent communication with the FDA to discuss the drug's development plan and ensure collection o

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye